Yttrium-90 ibritumomab tiuxetan combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for relapsed/refractory B-cell non-Hodgkin’s lymphoma No significant financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback